Janus Henderson Group’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,634
Closed -$98.4K 2556
2024
Q1
$98.4K Buy
10,634
+13
+0.1% +$152 ﹤0.01% 2510
2023
Q4
$136K Sell
10,621
-29
-0.3% -$302 ﹤0.01% 2500
2023
Q3
$110K Buy
10,650
+10
+0.1% +$116 ﹤0.01% 2504
2023
Q2
$140K Sell
10,640
-32
-0.3% -$391 ﹤0.01% 2530
2023
Q1
$119K Buy
+10,672
New +$105K ﹤0.01% 2599
2021
Q2
Sell
-152,082
Closed -$6.96M 1642
2021
Q1
$6.96M Sell
152,082
-222,231
-59% -$12.7M ﹤0.01% 958
2020
Q4
$25.8M Buy
+374,313
New +$18.3M 0.01% 697

Other funds holding LUNG

Janus Henderson Group's LUNG Position: Q2 2024 in Review

Janus Henderson Group sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 10,634 shares — an estimated $98.4K sold.

Janus Henderson Group first reported a position in LUNG in Q4 2020 and held it in 7 quarters. The position peaked at $25.8M in Q4 2020. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • Janus Henderson Group reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 10,634 Pulmonx shares in Q2 2024, an estimated $98.4K.
  • Janus Henderson Group first reported a position in Pulmonx in Q4 2020 and held it in 7 quarters.
  • Janus Henderson Group's Pulmonx position peaked at $25.8M in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.